-
公开(公告)号:US20240350456A1
公开(公告)日:2024-10-24
申请号:US18631821
申请日:2024-04-10
发明人: Ronaldo P. Ferraris , Nan Gao , Wei Vivian Li
IPC分类号: A61K31/4045 , A61K31/047 , A61K31/132 , A61K31/145 , A61K31/19 , A61K31/194 , A61K31/195 , A61K31/197 , A61K31/198 , A61K31/20 , A61K31/205 , A61K31/216 , A61K31/221 , A61K31/223 , A61K31/40 , A61K31/401 , A61K31/4015 , A61K31/404 , A61K31/405 , A61K31/4172 , A61K31/4188 , A61K31/455 , A61K31/51 , A61K31/513 , A61K31/522 , A61K31/609 , A61K31/66 , A61K31/685 , A61K31/7012 , A61K31/706 , A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K31/708 , A61P1/12 , C12Q1/6883 , G01N33/68
CPC分类号: A61K31/4045 , A61K31/047 , A61K31/132 , A61K31/145 , A61K31/19 , A61K31/194 , A61K31/195 , A61K31/197 , A61K31/198 , A61K31/20 , A61K31/205 , A61K31/216 , A61K31/221 , A61K31/223 , A61K31/40 , A61K31/401 , A61K31/4015 , A61K31/404 , A61K31/405 , A61K31/4172 , A61K31/4188 , A61K31/455 , A61K31/51 , A61K31/513 , A61K31/522 , A61K31/609 , A61K31/66 , A61K31/685 , A61K31/7012 , A61K31/706 , A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K31/708 , A61P1/12 , C12Q1/6883 , G01N33/6893 , C12Q2600/158 , G01N2800/06
摘要: Compositions and methods useful for the diagnosis and treatment of leaky gut syndrome and IBD including Crohn's disease are disclosed.
-
公开(公告)号:US20240302384A1
公开(公告)日:2024-09-12
申请号:US18547759
申请日:2022-03-03
申请人: APHP (ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS ) , UNIVERSITE PARIS , INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE ) , IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
发明人: Yoram BOUHNIK , Alexandre NUZZO , Olivier CORCOS , Marc-Emmanuel DUMAS , Antonis MYRIDAKIS , Dominique GAUGUIER
CPC分类号: G01N33/6893 , G01N33/5308 , G01N33/92 , G01N2570/00 , G01N2800/06 , G01N2800/7019
摘要: A metabolomic signature of acute mesenteric ischemia (AMI) and the determination thereof in a method for identifying a subject suffering or being at risk of suffering from AMI. Also, a kit that includes elements for determining the metabolomic signature of AMI and implementing the method for identifying a subject suffering or being at risk of suffering from AMI.
-
公开(公告)号:US20230375534A1
公开(公告)日:2023-11-23
申请号:US18247865
申请日:2021-10-05
发明人: Jeroen Raes , Sebastian Proost , Gwen Falony , Sara Manuel Araujo Vieira Da Silva , Nicholas John Timpson , David Allen Hughes
IPC分类号: G01N33/53
CPC分类号: G01N33/5308 , G01N2800/06
摘要: The disclosure relates to the field of the human gut microbiome, more particularly, to its effect on health and disease. Provided herein are means and methods to diagnose and treat or reduce the severity of gut flora dysbiosis as well as of gastro-intestinal inflammation and inflammation-associated disorders or conditions in a subject in need thereof.
-
公开(公告)号:US11679186B2
公开(公告)日:2023-06-20
申请号:US17201569
申请日:2021-03-15
申请人: Medtronic, Inc.
CPC分类号: A61M1/28 , A61B5/14507 , A61B5/6866 , A61M1/1601 , A61M1/1609 , A61M1/287 , A61M2205/3306 , A61M2205/3324 , A61M2205/50 , A61M2205/75 , G01N21/78 , G01N21/80 , G01N2021/7773 , G01N2021/7783 , G01N2021/7786 , G01N2800/06
摘要: The invention relates to a testing system and related methods for detecting peritonitis or infection in peritoneal dialysate removed from a patient. The testing system can include a fluid sensor apparatus in a fluid line of a peritoneal dialysis cycler through which spent peritoneal dialysate can be pumped. The fluid sensor apparatus can detect one or more markers associated with peritonitis or infection.
-
公开(公告)号:US20180356413A1
公开(公告)日:2018-12-13
申请号:US15778163
申请日:2016-11-23
申请人: MOLOGIC LIMITED
发明人: Gita Parekh
IPC分类号: G01N33/543 , G01N33/573 , G01N33/68 , B01L3/00 , A61M1/28
CPC分类号: G01N33/54306 , A61M1/1654 , A61M1/287 , A61M2210/0625 , A61M2210/1017 , A61M2210/12 , B01L3/5023 , B01L2200/026 , B01L2300/0663 , B01L2300/0672 , B01L2300/0825 , B01L2400/0406 , G01N33/573 , G01N33/6869 , G01N2333/5412 , G01N2333/96494 , G01N2800/06 , G01N2800/52
摘要: A diagnostic test apparatus comprises: an elongate housing defining a test strip holder containing a lateral flow test strip; a fluid sampling chamber provided with an opening connecting the fluid sampling chamber with the test strip holder; a viewing window in the elongate housing allowing reading of one or more portions of the lateral flow test strip; and a connector configured to couple the diagnostic test apparatus to a bulk source of fluid. The apparatus may be included in a kit of parts. The apparatus is useful for detecting peritonitis. The bulk source of fluid may be peritoneal dialysate. Various markers may be determined in the bulk source of fluid such as MMP8, IL-6, HNE, MMP2, MMP9, TIMP1, TIMP2, NGAL, A1AT, desmosine, fibrinogen, IL-8, calprotectin, fMLP, IL1b, cystatin C, HSA, RBP4, SPD, MPO, sICAM and TNFa. Detection of the markers to indicate peritonitis may also inform treatment choices.
-
公开(公告)号:US20180313849A1
公开(公告)日:2018-11-01
申请号:US16011043
申请日:2018-06-18
申请人: Kenneth Davin Fine
发明人: Kenneth Davin Fine
IPC分类号: G01N33/68
CPC分类号: G01N33/6854 , G01N33/6893 , G01N2800/06 , G01N2800/24
摘要: In various implementations, a noninvasive, veterinary diagnostic test may be utilized to identify one or more immunologic food sensitivities. A fecal sample may be obtained. The veterinary diagnostic test may be performed on the obtained fecal sample. One or more immunologic food sensitivities may be identified based on the veterinary diagnostic test.
-
公开(公告)号:US20180259503A1
公开(公告)日:2018-09-13
申请号:US15981244
申请日:2018-05-16
申请人: BIOGAIA AB
发明人: Eamonn Conolly , Wolfgang Kunze , John Bienenstock
CPC分类号: G01N33/5041 , A61K35/74 , A61K45/06 , A61K2035/11 , G01N33/6872 , G01N33/6893 , G01N2333/705 , G01N2800/06
摘要: The present embodiments relate to selection of agents effective in reducing or preventing gastrointestinal pain in a subject. Such an agent is selected and identified if it is capable of reducing spontaneous and/or induced transient receptor potential vanilloid 1 (TRPV1) activation.
-
公开(公告)号:US20180135127A1
公开(公告)日:2018-05-17
申请号:US15521224
申请日:2015-10-22
IPC分类号: C12Q1/6883
CPC分类号: C12Q1/6883 , C12Q2600/158 , G01N33/566 , G01N33/6893 , G01N33/84 , G01N2500/04 , G01N2800/06 , G01N2800/56
摘要: The invention relates to methods and kits for diagnosing and/or treating appendicitis in a subject, comprising obtaining a biological sample from said subject; detecting RNA expression levels of at least three or more biomarkers in the biological sample and comparing the expression levels of said at least three or more biomarkers to a control sample wherein an increase or decrease in the level of expression of said at least three or more biomarkers as compared to the control sample is indicative of appendicitis.
-
公开(公告)号:US09952223B2
公开(公告)日:2018-04-24
申请号:US15609959
申请日:2017-05-31
发明人: Mark Pimentel , Christopher Chang
CPC分类号: G01N33/6887 , A61K38/1709 , G01N33/564 , G01N2333/4703 , G01N2333/705 , G01N2800/06 , G01N2800/065 , G01N2800/2842
摘要: Described herein are methods and systems for the detection of anti-vinculin antibodies, for determining a presence or likely presence of a gastrointestinal motility disorder, bladder motility disorder, or fibromyalgia. Further provided are methods of selecting and/or administering a therapy based on the presence or absence of anti-vinculin antibodies.
-
公开(公告)号:US20180100200A1
公开(公告)日:2018-04-12
申请号:US15809162
申请日:2017-11-10
发明人: Lawrence Charles LAPOINTE , Robert DUNNE , Graeme P. YOUNG , Trevor John LOCKETT , William J. WILSON
IPC分类号: C12Q1/68 , G01N33/574
CPC分类号: C12Q1/6886 , C12Q2600/112 , C12Q2600/158 , C12Q2600/16 , G01N33/57446 , G01N2800/06
摘要: The present invention relates generally to nucleic acid molecules, the RNA and protein expression profiles of which are indicative of the onset, predisposition to the onset and/or progression of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules, the expression profiles of which are indicative of the onset and/or progression of a large intestine neoplasm, such as an adenoma or an adenocarcinoma. The expression profiles of the present invention are useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinomas. Accordingly, in a related aspect the present invention is directed to a method of screening a subject for the onset, predisposition to the onset and/or progression of a neoplasm by screening for modulation in the expression profile of one or more nucleic acid molecule markers.
-
-
-
-
-
-
-
-
-